1. Medtech Insight
  2. >>Business

Teleflex Continues Restructuring By Selling Hudson Respiratory Business To Medline

 
• By Reed Miller

Medline will pay $286m in cash for Teleflex's oxygen and aerosol therapy, active humidification, and non-invasive ventilation devices as well as incentive spirometers. Those businesses yielded $139m in 2020 revenues, but do not fit into Teleflex's plan for the future.

Attaching a puzzle to an assembly, a new employee. Recruiting specialists candidates for a new project. Expanding the staff of business company. Team - Image ID: 2FK4Y1E
• Source: Alamy

Teleflex is selling some of its respiratory device assets to focus more resources on its core vascular, anesthesia, surgical and interventional urology businesses.

On 18 May, Teleflex announced a definitive agreement to sell a significant portion of its Hudson RCI brand of respiratory products to Illinois-based Medline Industries, Inc. for $286m in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind

 
• By Shubham Singh

The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 
• By Natasha Barrow

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.